CardioMEMS HF System

Sign up to receive email updates on the CardioMEMS™ HF System  

Sign Up Today

The CardioMEMS™ HF System

CardioMEMS™ HF System

St. Jude Medical is proud to introduce a new tool for comprehensive heart failure care. The CardioMEMS™ HF System is the first and only FDA-approved heart failure (HF) monitoring system proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class III patients.1

When used by clinicians to manage heart failure,
the CardioMEMS HF System is:

  • Safe and reliable – 98.6% of patients were free from device or system complications2
  • Clinically proven – reduced HF admissions by 37%2
  • Proactive and personalized – patient management through direct monitoring of PA pressure and titration of medications

Learn more about the CardioMEMS HF System:

For Physicians | For Patients

CardioMEMS™ HF System
Clinical Protocol Example

Philip B Adamson MD, MSc, FACC.Philip B Adamson MD, MSc, FACC.
Medical Director St. Jude Medical, the former Director Heart Failure Institute at Oklahoma Heart Hospital, shares his experience with patient management of heart failure using PA Pressure.

Read the Clinical Protocol

On Demand Webinars

Discover the CardioMEMS™ HF System –
A Game Changer For HF Patient Management

This webinar series covers topics including guidelines for managing heart failure using PA pressure, ambulatory PA pressure treatment strategies and implementing the CardioMEMS™ HF System into the management of your heart failure patients.

Find all the Webinars


Data from HRS 2015

Cost Effectiveness Assessment of Pulmonary Artery Pressure Monitoring for Heart Failure Management

Presenter: Philip Adamson, MD

Read the Abstract

Pressure for Action: Implantable Pulmonary Artery Pressure Sensor Measurements Alone Beat Clinical Signs to Guide Prevention of Heart Failure Hospitalizations

Presenter: Lee Goldberg, MD, MPH

Read the Abstract  

Pulmonary Artery Pressure Management in Heart Failure Patients with Cardiac Resynchronization Therapy or Implantable Cardioverter Defibrillator Devices Significantly Reduces Hospitalizations and Mortality Above and Beyond Background Guideline-Directed Medical

Presenter: William Abraham, MD

Read the Abstract



1. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet. 2011;377(9766):658-66.
2. Adamson et al., Impact of Wireless Pulmonary Artery Pressure Monitoring on Heart Failure Hospitalizations and 30-Day Readmissions in Medicare-Eligible Patients with NYHA Class III Heart Failure: Results from the CHAMPION Trial AHA 2014, Chicago. Abstract 16744.

Indications, Safety & Warnings